Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

The first time round, 59-year-old James Brown lost a stone and a half when he took medication that aids weight loss. This ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

Inadequate supply has created opportunities for bad actors seeking to profit from shortages, high costs and demand ...

Weight loss injections work by making you feel fuller and less hungry. There are plenty of weight loss medication options to ...

Report from Canada’s Drug Agency says Wegovy cuts risk of heart attack, stroke or cardiovascular death by 20 per cent ...

Swiss pharma giant Novartis is diving into research on ageing to tap the growing market for drugs that help keep older adults ...

Employers have the opportunity to lead by example: to stop treating obesity as invisible and start addressing it as the ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...